Crisnatol mesylate: Phase I dose escalation by extending infusion duration
- 1 February 1991
- journal article
- clinical trial
- Published by Springer Nature in Investigational New Drugs
- Vol. 9 (1) , 41-47
- https://doi.org/10.1007/bf00194543
Abstract
No abstract availableKeywords
This publication has 4 references indexed in Scilit:
- PHASE-I AND CLINICAL-PHARMACOLOGY TRIAL OF CRISNATOL (BWA770U MESYLATE) USING A MONTHLY SINGLE-DOSE SCHEDULE1988
- Pharmacokinetically guided dose escalation in phase I clinical trials. Commentary and proposed guidelinesEuropean Journal of Cancer and Clinical Oncology, 1987
- Potential roles for preclinical pharmacology in phase I clinical trials.1986
- Reporting results of cancer treatmentCancer, 1981